肿瘤诊治与预后专栏

精细化甲状腺被膜解剖技术联合环甲隙显露喉返神经方法对分化型甲状腺癌患者创伤应激指标的影响

  • 吕庆福 ,
  • 高凌 ,
  • 过兆基
展开
  • 苏州大学附属第一医院普外科 (江苏 苏州 215008 )

收稿日期: 2025-12-05

  修回日期: 2025-12-20

  录用日期: 2025-12-23

  网络出版日期: 2026-03-26

基金资助

国家自然科学基金项目(81974375)

The effect of meticulous capsule dissection technique combined with recurrent laryngeal nerve on trauma stress indicators in differentiated thyroid cancer patients

  • Qingfu Lü ,
  • Ling GAO ,
  • Zhaoji GUO
Expand
  • Department of General Surgery,the First Affiliated Hospital of Soochow University,Suzhou 215008,Jiangsu,China

Received date: 2025-12-05

  Revised date: 2025-12-20

  Accepted date: 2025-12-23

  Online published: 2026-03-26

摘要

目的 探讨分化型甲状腺癌(DTC)患者经精细化甲状腺被膜解剖技术(MCDT)联合环甲隙显露喉返神经方法(RLN)治疗的效果。 方法 选自2023年12月至2024年12月苏州大学附属第一医院收治的DTC患者,按照1∶1比例与手术方法的不同纳入A组(常规术式联合甲状腺下动脉显露喉返神经法)和B组(MCDT联合RLN)各58例,共纳入116例。两组术后均随访6个月。比较两组近期疗效(术后6个月)、围术期指标、声带功能、甲状腺功能(术前、术后6个月)、创伤应激指标(术前、术后1 d)及并发症(随访期间)。 结果 随访6个月后,B组总有效率为94.83%,高于A组的79.31%(P < 0.05)。B组住院时间短于A组(P < 0.05)。与术前比较,术后6个月,两组振幅微扰、基频微扰、标准化噪声能量(NNE)及血清甲状腺刺激抗体(TSAb)、甲状腺刺激阻断性抗体(TSBAb)、促甲状腺激素受体抗体(TRAb)水平均降低,且B组更低;两组谐波噪声比(HNR)均升高,血清甲状旁腺激素(PTH)水平均降低,B组均更高(P < 0.05);两组血清促甲状腺激素(TSH)水平均降低,但两组比较差异无统计学意义(P > 0.05)。与术前比较,术后1 d,两组创伤应激指标水平均升高,但B组更低(P < 0.05)。B组随访期间并发症发生率更低(P < 0.05)。 结论 MCDT联合RLN治疗DTC有助于缩短住院时间,减轻患者创伤应激,并改善患者声带功能及甲状腺功能,进而提高临床疗效,且具有较高安全性。

本文引用格式

吕庆福 , 高凌 , 过兆基 . 精细化甲状腺被膜解剖技术联合环甲隙显露喉返神经方法对分化型甲状腺癌患者创伤应激指标的影响[J]. 实用医学杂志, 2026 , 42(6) : 952 -958 . DOI: 10.3969/j.issn.1006-5725.2026.06.007

Abstract

Objective To explore the therapeutic effect of meticulous capsule dissection technique (MCDT) combined with recurrent laryngeal nerve (RLN) protection in patients with differentiated thyroid cancer (DTC). Methods The research subjects were selected from patients with DTC who were admitted to the First Affiliated Hospital of Soochow University. The inclusion period for the cases was from December 2023 to December 2024. According to a 1∶1 ratio and different surgical methods, 58 cases were assigned to Group A (conventional surgical procedure combined with exposure of the recurrent laryngeal nerve via the inferior thyroid artery), and 58 cases were assigned to Group B (MCDT combined with RLN), making a total of 116 cases. Both groups were followed up for 6 months after surgery. The short-term efficacy (follow-up for 6 months), perioperative indicators (including vocal cord function and thyroid function before and 6 months after surgery), trauma stress indicators (before and 1 day after surgery), and complications (during the follow-up period) of the two groups were compared. Results After 6 months of follow-up, the total effective rate of group B was 94.83%, which was higher than that of group A (79.31%, P < 0.05). The length of hospitalization in group B was shorter than that in group A (P < 0.05). Compared with the pre-surgery state, 6 months after surgery, both groups showed a decrease in amplitude perturbation, fundamental frequency perturbation, normalized noise energy (NNE), and serum levels of thyroid stimulating antibody (TSAb), thyroid stimulating blocking antibody (TSBAb), and thyroid stimulating hormone receptor antibody (TRAb), with lower values in group B. Both groups showed an increase in harmonic noise ratio (HNR) and a decrease in serum parathyroid hormone (PTH) levels, with higher values in group B (P < 0.05). Both groups showed a decrease in serum thyroid stimulating hormone (TSH) levels, but there was no significant difference between the two groups (P > 0.05). Compared with the pre-surgery state, the levels of serum trauma stress indicators increased in both groups 1 day after surgery, but the values in group B were lower (P < 0.05). During the follow-up period, the incidence of complications in group B was lower (P < 0.05). Conclusion The combination of MCDT and RLN can help shorten the hospitalization time, reduce traumatic stress, improve the vocal cord function and thyroid function in patients with DTC, thereby enhancing the clinical efficacy and ensuring high safety.

参考文献

[1] VOLPE F, NAPPI C, ZAMPELLA E, et al. Current advances in radioactive iodine-refractory differentiated thyroid cancer[J]. Curr Oncol, 2024, 31(7): 3870-3884. doi:10.3390/curroncol31070286 .
[2] ULLMANN T M, PAPALEONTIOU M, SOSA J A. Current controversies in low-risk differentiated thyroid cancer: Reducing overtreatment in an era of overdiagnosis[J]. J Clin Endocrinol Metab, 2023, 108(2): 271-280. doi:10.1210/clinem/dgac646 .
[3] MALLICK U, NEWBOLD K, BEASLEY M, et al. Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): A randomised, multicentre, non-inferiority trial[J]. Lancet, 2025, 406(10498): 52-62. doi:10.1016/S0140-6736(25)00629-4 .
[4] ALAM I S, PATEL K N. Management of poorly differentiated thyroid cancer and differentiated high-grade thyroid carcinoma[J]. Surg Clin North Am, 2024, 104(4): 751-765. doi:10.1016/j.suc.2024.02.005 .
[5] 程若川. 分化型甲状腺癌术后促甲状腺激素抑制治疗现状和思考[J]. 中国实用外科杂志, 2023, 43(4): 391-396. doi:10.19538/j.cjps.issn1005-2208.2023.04.05 .
[6] FACKELMAYER O J, INABNET W B 3rd. Lobectomy or total thyroidectomy-where is the pendulum now for differentiated thyroid cancer?[J]. Surg Oncol Clin N Am, 2023, 32(2): 373-381. doi:10.1016/j.soc.2022.10.011 .
[7] LI G, SHAO Y, WANG X, et al. Assessment of age as different variable types for determining survival in differentiated thyroid cancer[J]. Endocrine, 2022, 78(1): 104-113. doi:10.1007/s12020-022-03148-y .
[8] VAN VELSEN E F S, PEETERS R P, STEGENGA M T, et al. Evaluating disease-specific survival prediction of risk stratification and TNM systems in differentiated thyroid cancer[J]. J Clin Endocrinol Metab, 2023, 108(6): e267-e274. doi:10.1210/clinem/dgac721 .
[9] 中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南[J]. 中华内分泌代谢杂志, 2012, 28(10): 779-797. doi:10.3760/cma.j.issn.1000-6699.2012.10.002 .
[10] 刘峥嵘, 冯国勋, 俞巍. 经口腔前庭全腔镜下甲状腺癌根治术对分化型甲状腺癌患者近期疗效及预后的影响[J]. 临床和实验医学杂志, 2025, 24(2): 184-188. doi:10.3969/j.issn.1671-4695.2025.02.019 .
[11] 胡徐意, 杨洋, 黄文华. 无张力性喉返神经端端吻合修复术的临床解剖学研究[J]. 中国临床解剖学杂志, 2024, 42(6): 627-633. doi:10.13418/j.issn.1001-165x.2024.6.03 .
[12] CHOI S M, KIM D G, LEE J E, et al. Thyroid lobectomy is sufficient for differentiated thyroid cancer with upgraded risk after surgery[J]. Gland Surg, 2022, 11(9): 1451-1463. doi:10.21037/gs-22-158 .
[13] NIEDERLE M B, BINTER T, RISS P, et al. Tailored surgery for medullary thyroid cancer (MTC) based on pretherapeutic basal calcitonin and intraoperative diagnosis of desmoplastic stroma reaction: A proposal for a new surgical concept[J]. Ann Surg Oncol, 2025, 32(7): 4742-4753. doi:10.1245/s10434-025-16958-x .
[14] JEONG S Y, CHUNG S R, BAEK J H, et al. Sonographic assessment of minor extrathyroidal extension of papillary thyroid microcarcinoma involving the posterior thyroid capsule[J]. Eur Radiol, 2022, 32(9): 6090-6096. doi:10.1007/s00330-022-08765-9 .
[15] WENG Y J, KWAN K J S, CHEN D B, et al. Subcutaneous implantation of nodular goiter after transoral endoscopic thyroidectomy vestibular approach: A case study and review of literature[J]. Head Neck, 2024, 46(6): E61-E66. DOI:10.1002/hed.27732 doi:10.1002/hed.27732 .
[16] CONRADIE W, LUVHENGO T, LüBBE J A, et al. The clinicopathological landscape of thyroid cancer in South Africa—A multi-institutional review[J]. World J Surg, 2024, 48(12): 2863-2870. doi:10.1002/wjs.12353 .
[17] 匡风霞, 赵晓虹, 韩宝佳, 等. 对控制机器人甲状腺癌根治术患者手术应激反应麻醉深度的探讨[J]. 山东大学学报(医学版), 2022, 60(5): 81-86. doi:10.6040/j.issn.1671-7554.0. 2021.1315 .
[18] GUO J, XIAO N, ZHANG J. Predictive value of the estimation of physiologic ability and surgical stress for postoperative recurrent laryngeal nerve injury in patients with type 2 diabetes mellitus complicated by thyroid cancer: A retrospective cohort study[J]. Br J Hosp Med, 2025, 86(8): 1-12. doi:10.12968/hmed. 2025. 0234 .
[19] ZHAO J, LI L M, GAO L, et al. Prediction model construction of cervical central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto′s thyroiditis utilizing conventional ultrasound and elastography[J]. Gland Surg, 2024, 13(12): 2325-2334. doi:10.21037/gs-24-271 .
[20] BEDNARCZYK A, KOWALSKI G, GAWRYCHOWSKA A, et al. Transforming growth factor-beta (TGF-β) dynamics in thyroid pathologies: A comprehensive analysis of pre- and post-surgery levels in differentiated thyroid cancer and nodular goiter[J]. Pol Przegl Chir, 2024, 97(2): 1-4. doi:10.5604/01.3001. 0054. 8492 .
[21] 李欣, 姚响芸, 黄九平, 等. 基于术前高频超声测量的喉返神经喉外分支的预测研究[J]. 中国临床解剖学杂志, 2025, 43(5): 536-539. doi:10.13418/j.issn.1001-165x.2025.5.06 .
文章导航

/